Biopsy-proven metabolic dysfunction-associated steatotic liver disease is linked to a higher risk for a composite chronic kidney disease outcome, a Swedish study shows.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/biopsy-proven-masld-linked-increased-risk-chronic-kidney-2026a1000m7i?src=rss
Author :
Publish date : 2026-07-02 12:00:00
Copyright for syndicated content belongs to the linked Source.
